Identification of Farnesyl Pyrophosphate and N-Arachidonylglycine as Endogenous Ligands for GPR92S
A series of small compounds acting at the orphan G protein-coupled receptor GPR92 were screened using a signaling pathway-specific reporter assay system. Lipid-derived molecules including farnesyl pyrophosphate (FPP), N -arachidonylglycine (NAG), and lysophosphatidic acid were found to activate GPR9...
Saved in:
Published in: | The Journal of biological chemistry Vol. 283; no. 30; pp. 21054 - 21064 |
---|---|
Main Authors: | , , , , , , , , , , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
American Society for Biochemistry and Molecular Biology
25-07-2008
|
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | A series of small compounds acting at the orphan G protein-coupled receptor
GPR92 were screened using a signaling pathway-specific reporter assay system.
Lipid-derived molecules including farnesyl pyrophosphate (FPP),
N
-arachidonylglycine (NAG), and lysophosphatidic acid were found to
activate GPR92. FPP and lysophosphatidic acid were able to activate both
G
q/11
- and G
s
-mediated signaling pathways, whereas NAG
activated only the G
q/11
-mediated signaling pathway.
Computer-simulated modeling combined with site-directed mutagenesis of GPR92
indicated that Thr
97
, Gly
98
, Phe
101
, and
Arg
267
of GPR92 are responsible for the interaction of GPR92 with
FPP and NAG. Reverse transcription-PCR analysis revealed that GPR92 mRNA is
highly expressed in the dorsal root ganglia (DRG) but faint in other brain
regions. Peripheral tissues including, spleen, stomach, small intestine, and
kidney also expressed GPR92 mRNA. Immunohistochemical analysis revealed that
GPR92 is largely co-localized with TRPV1, a nonspecific cation channel that
responds to noxious heat, in mouse and human DRG. FPP and NAG increased
intracellular Ca
2+
levels in cultured DRG neurons. These results
suggest that FPP and NAG play a role in the sensory nervous system through
activation of GPR92. |
---|---|
Bibliography: | The on-line version of this article (available at http://www.jbc.org) contains supplemental Figs. 1-4. This work was supported, in whole or in part, by National Institutes of Health Grants DA16825 and DA018224 from the National Institute on Drug Abuse (to J. M. W.). This work was also supported by Grants M103KV010005-08K2201-00510 (to J. Y. S.) and M103KV010007-07K2201-00710 (to H. R.) from the Brain Research Center of the 21st Century Frontier Research Program; the Linda and Jack Gill Center for Biomolecular Science, Indiana University, Bloomington, IN; and the Indiana Metabolomics and Cytomics Initiative (METACyt) Grant from Lilly Foundation Inc., Indianapolis, IN. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. Passed away on January 5, 2008 in Bloomington, IN. This paper is dedicated to the memory of J. Michael Walker. |
ISSN: | 0021-9258 1083-351X |
DOI: | 10.1074/jbc.M708908200 |